Lexaria Bioscience's total assets for Q were $10.02M, an increase of 57.72% from the previous quarter. LEXX total liabilities were $271.38K for the fiscal quarter, a 32.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.